ZIVO BIOSCIENCE, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
ZIVO BIOSCIENCE, INC. (ZIVO) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $1.35 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-18.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2025-03-18
- ZIVO BIOSCIENCE, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $1.35M, a 14.58% decline from fiscal 2023.
- ZIVO BIOSCIENCE, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $1.58M, a 6.94% decline from fiscal 2022.
- ZIVO BIOSCIENCE, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $1.70M, a 19.03% decline from fiscal 2021.
- ZIVO BIOSCIENCE, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was $2.10M, a 8.66% decline from fiscal 2020.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2024-12-31 | $1.35M 10-K · filed 2025-03-18 | |
| 2023-12-31 | $1.58M 10-K · filed 2024-03-15 | |
| 2022-12-31 | $1.70M 10-K · filed 2024-03-15 | |
| 2021-12-31 | $2.10M 10-K · filed 2023-03-14 | $2.51M 10-K · filed 2022-04-22 |
| 2020-12-31 | $2.30M 10-K · filed 2022-04-22 |